New lab study reveals how breast cancer drug can accelerate cancer cell growth
(The Francis Crick Institute) The breast cancer drug lapatinib which is designed to shrink tumors can sometimes cause them to grow in the lab, according to a new study. By understanding the molecular basis of this phenomenon, scientists hope that their findings will lead to safer treatment decision-making and drug design in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP {beta}2-chimaerin
The role of vascular endothelial growth factor (VEGF) signaling in cancer is not only well known in the context of angiogenesis but also important in the functional regulation of tumor cells. Autocrine VEGF signaling mediated by its co-receptors called neuropilins (NRPs) appears to be essential for sustaining the proliferation and survival of cancer stem cells (CSCs), which are implicated in mediating tumor growth, progression, and drug resistance. Therefore, understanding the mechanisms involved in VEGF-mediated support of CSCs is critical to successfully treating cancer patients. The expression of the Hippo effector TAZ ...
Source: Signal Transduction Knowledge Environment - May 1, 2018 Category: Science Authors: Elaimy, A. L., Guru, S., Chang, C., Ou, J., Amante, J. J., Zhu, L. J., Goel, H. L., Mercurio, A. M. Tags: STKE Research Articles Source Type: news

New Model Can Assess Breast Cancer Risk in Women With Atypical Hyperplasia
Researchers have developed a new model to help predict the development of breast cancer in women with atypical hyperplasia based on a breast biopsy. (Source: CancerNetwork)
Source: CancerNetwork - April 30, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Similar Risk Predicted for Automated, Clinical BI-RADS Density
MONDAY, April 30, 2018 -- Automated and clinical Breast Imaging Reporting and Data System (BI-RADS) density measures similarly predict breast cancer risk, according to a study published online May 1 in the Annals of Internal Medicine. Karla... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

Doctor shares myth-busting truths about breast cancer
Dr. Kristi Funk shares her tips in her new book, "Breasts: The Owner's Manual." (Source: ABC News: Health)
Source: ABC News: Health - April 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Breast cancer: Potential new treatment for aggressive form of the cancer
BREAST cancer sufferers may be twice as likely to benefit from a drug used to treat ovarian cancer, says a groundbreaking study out today set to change international clinical guidelines. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

Breast cancer treatment: Potential new treatment for aggressive form of the cancer
BREAST cancer sufferers may be twice as likely to benefit from a drug used to treat ovarian cancer, says a groundbreaking study out today set to change international clinical guidelines. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

PARP Drugs Help Some Breast Cancer Patients, But They're No Magic Bullet
For patients with metastatic breast cancer, doctors don ’t yet know how to predict long-term responses to this PARP drug. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 30, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:AZN NYSE:PFE Source Type: news

PARP Drugs Help Some Metastatic Breast Cancer Patients, But They're No Magic Bullet
Lynparza is a pill, usually taken twice daily. It ’s convenient and generally well-tolerated. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 30, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:AZN NYSE:PFE Source Type: news

Beverley Craven: 'I’ll never get over losing my sister to cancer'
MOST of us have been affected by cancer but for Beverley Craven it has been an uncomfortably close and continuing encounter. The singer, now 54, won her own battle with breast cancer but she lost her sister and a cousin to the disease when they were in their 40s. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

WATCH: Renowned breast cancer surgeon Dr. Kristi Funk opens up about her new book
The doctor discusses the major takeaways from her new book, "Breasts: the Owner's Manual: Every Woman's Guide to Reducing Cancer Risk, Making Treatment Choices, and Optimizing Outcomes." (Source: ABC News: Health)
Source: ABC News: Health - April 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Breast Cancer Risk and Tamoxifen Use
Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 30, 2018 Category: General Medicine Source Type: news

Computers equal radiologists in assessing breast density and associated breast cancer risk
(University of California - San Francisco) Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2018 Category: Cancer & Oncology Source Type: news

Targeting chemotherapy with genetic testing benefits women with aggressive breast cancer
(Institute of Cancer Research) Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports. Researchers found that women with advanced 'triple-negative' breast cancer who had inherited a BRCA mutation were twice as likely to benefit from carboplatin as docetaxel, which is currently standard of care for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2018 Category: Cancer & Oncology Source Type: news

Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
(DOE/Sandia National Laboratories) A long-standing collaboration between Sandia National Laboratories and Imagion Biosystems produced precise magnetic nanoparticles for a breast cancer clinical trial later this year. The nanoparticles stick to breast cancer cells, allowing the detection and removal of even small metastases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2018 Category: International Medicine & Public Health Source Type: news

Pill for breast cancer diagnosis may outperform mammograms
(University of Michigan) As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2018 Category: International Medicine & Public Health Source Type: news

Getting off opioids with medical marijuana: Patients turn to pot over pills
In 2016, opioids killed more Americans than breast cancer. The drug overdose epidemic has become one of the most concerning public health issues of recent time, and in an effort to stem the tide, moreg and more patients and doctors are turning to pot over pills. (Source: CNN.com - Health)
Source: CNN.com - Health - April 29, 2018 Category: Consumer Health News Source Type: news

One woman's journey to find a spa that would admit her despite industry wide health fear myths
My best medicine has always been a day of pampering. Until, that is, December 2016, when I was diagnosed with breast cancer and my body suddenly became unworthy. (Source: the Mail online | Health)
Source: the Mail online | Health - April 28, 2018 Category: Consumer Health News Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Breast Cancer and African Ancestry
In this video, Dr. Melissa Davis explains how African ancestry may play a role in breast cancer, and ways that genetics might be used to help guide treatment. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2018 Category: Cancer & Oncology Authors: Melissa Davis, PhD Tags: Conferences/AACR Street Team Breast Cancer News Source Type: news

Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen
A small study in the UK has found 6 of 7 women with a family history of breast cancer opted out of taking tamoxifen as a preventive measure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Investor Update)
Source: Roche Investor Update - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
Title: Breast Cancer Genes a Real Risk for Men, TooCategory: Health NewsCreated: 4/26/2018 12:00:00 AMLast Editorial Review: 4/27/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 27, 2018 Category: Cancer & Oncology Source Type: news

ARRS: Screening mammography is effective in younger women
Screening mammography in women ages 40 to 49 finds almost 20% more cancers...Read more on AuntMinnie.comRelated Reading: How serious is the risk of breast cancer overdiagnosis? DBT improves breast cancer screening in young women Mammography finds more cancers in younger women SABCS: Biannual breast MRI best for young women at high risk DBT in younger women mitigates mammography's 'harms' (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2018 Category: Radiology Source Type: news

Chest Wall Resection for Recurrent Breast Cancer Chest Wall Resection for Recurrent Breast Cancer
The utility of full-thickness chest wall resection for recurrent breast cancer has been debated. Is it time for a new way of thinking?Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 27, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - April 27, 2018 Category: Cancer & Oncology Source Type: news

Bra tattoo changed woman's life after breast cancer
A 69-year-old breast cancer survivor gets her confidence back after having a bra tattoo. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
BRCA1 and BRCA2 gene mutations put women at high risk for breast and ovarian cancers, but  these mutations also increase men's risk for certain cancers. (Source: WebMD Health)
Source: WebMD Health - April 26, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 26, 2018 Category: Cancer & Oncology Tags: Oncology, Reproductive Medicine, Research, Preventive Medicine, News, Source Type: news

Breast cancer warning - what does a cancerous lump feel like?
BREAST cancer symptoms include lumps, a change in the shape of one or both breasts, and a lump in either of your armpits. But, what exactly are you supposed to be feeling for when checking your breasts for lumps? This is what a cancerous lump could feel like. (Source: Daily Express - Health)
Source: Daily Express - Health - April 26, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
THURSDAY, April 26, 2018 -- Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals. BRCA1 and BRCA2 gene mutations put women at high risk for breast and ovarian... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2018 Category: General Medicine Source Type: news

Epigenetic Changes May Drive Racial Differences in ER-negative Breast Tumors Epigenetic Changes May Drive Racial Differences in ER-negative Breast Tumors
Epigenetic changes may help explain racial disparities in estrogen receptor (ER)-negative breast cancer, say researchers from Roswell Park Comprehensive Cancer Center in Buffalo, New York.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Estrogen Safe After Oophorectomy in BRCA Mutation Carriers Estrogen Safe After Oophorectomy in BRCA Mutation Carriers
Use of estrogen-alone hormone replacement therapy (HRT) after oophorectomy does not increase the risk of BRCA 1-associated breast cancer, although this may not be the case for progesterone-continuing HRT, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Patient navigation for cancer screening: A mixed bag
Patient navigation services can be a helpful way to support cancer screening...Read more on AuntMinnie.comRelated Reading: Breast MR: Is it accessible to women who need it? NCoBC: 3 ways nurse navigators can reduce your malpractice risk NCoBC: Mammography techs play crucial role in women's health NCBC signs deal to train health navigators Patient navigation speeds breast cancer diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2018 Category: Radiology Source Type: news

FDA Declines to Approve Pfizer Biosimilar of Roche's Cancer Drug FDA Declines to Approve Pfizer Biosimilar of Roche's Cancer Drug
Pfizer Inc said on Monday U.S. regulators declined to approve the company ’ s biosimilar of Roche ’ s blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Pharmacist News Source Type: news

Surgeon struck with same cancer as her patients reflects: 'I never imagined'
When Dr. Anne Peled, a 37-year-old breast cancer surgeon and mother of three, was struck by the same cancer as her patients, her world changed. (Source: ABC News: Health)
Source: ABC News: Health - April 25, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Palliative Care Questions to Ask Every Advanced Cancer Patient Palliative Care Questions to Ask Every Advanced Cancer Patient
Tips on making palliative care discussions a routine part of advanced breast cancer treatment.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

New breath and urine tests detect early breast cancer more accurately
(American Associates, Ben-Gurion University of the Negev) " Breast cancer survival is strongly tied to the sensitivity of tumor detection; accurate methods for detecting smaller, earlier tumors remains a priority, " says Prof. Yehuda Zeiri, a member of Ben-Gurion University's Department of Biomedical Engineering. " Our new approach utilizing urine and exhaled breath samples, analyzed with inexpensive, commercially available processes, is non-invasive, accessible and may be easily implemented in a variety of settings. " (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 25, 2018 Category: Cancer & Oncology Source Type: news

Circulating Tumor Cell Count Predicts Early Breast Cancer Outcomes Circulating Tumor Cell Count Predicts Early Breast Cancer Outcomes
Circulating tumor cell (CTC) count independently predicts outcomes in women with early breast cancer treated with neoadjuvant chemotherapy, according to a meta-analysis.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 24, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

QoL Data Support APBI for Early Breast Cancer (CME/CE)
(MedPage Today) -- Early swelling, pain, and skin problems worse with whole-breast irradiation (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 24, 2018 Category: Hematology Source Type: news

One in seven women taking pills which help prevent breast cancer
Only one in seven who are at high risk of breast cancer are taking Tamoxifen to reduce their chances of getting the disease, a study found. (Source: the Mail online | Health)
Source: the Mail online | Health - April 24, 2018 Category: Consumer Health News Source Type: news

ARRS: Added radiation exposure from DBT is within limits
WASHINGTON, DC - While digital breast tomosynthesis (DBT) increases radiation...Read more on AuntMinnie.comRelated Reading: DBT improves breast cancer screening in young women FDA authorizes ACR to accredit DBT devices DBT know-how boosts FFDM recall, cancer detection rates Deep learning may produce sharp reductions in DBT dose DBT screening shows greatest benefit for younger women (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2018 Category: Radiology Source Type: news

Changes in breast tissue increase cancer risk for older women
(Cell Press) Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April 24 in the journal Cell Reports, may help scientists better understand how breast cells change during the aging process, enabling doctors to catch the signs of cancer earlier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 24, 2018 Category: Cancer & Oncology Source Type: news

A non-coding RNA lasso catches proteins in breast cancer cells
(Aarhus University) A Danish-German research team has shown that not only the where and when of long non-coding RNA expression is important for their function but also the how. The results can have a big impact on our understanding of dynamic regulation of gene expression in biological processes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2018 Category: International Medicine & Public Health Source Type: news

Prognostic Tool Can Guide Extended Endocrine Therapy in ER+ Breast Cancer
A simple prognostic tool could be used to identify patients with HR-positive breast cancer who underwent 5 years of endocrine treatment and who might be at higher risk of late distant recurrence. (Source: CancerNetwork)
Source: CancerNetwork - April 24, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Forecasting PARP Inhibitor Resistance in Breast Cancer Patients
In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in ovarian cancer, and the importance of understanding how resistance to these agents develops. (Source: CancerNetwork)
Source: CancerNetwork - April 23, 2018 Category: Cancer & Oncology Authors: Elizabeth Swisher, MD Tags: Conferences/AACR Street Team Breast Cancer News Source Type: news

Shimadzu Corporation Releases New LIGHTVISION Near-infrared Fluorescence Imaging System
The LIGHTVISION near-infrared fluorescence imaging system is for visualizing lymph and blood vessels to support treatment of breast cancer KYOTO, Japan, April 23, 2018 -- (Healthcare Sales & Marketing Network) -- Shimadzu Corporation has entered the m... Devices, Product Launch Shimadzu, LIGHTVISION, near-infrared fluorescence, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news